A Phase 1 Trial in Healthy Participants to Evaluate the Pharmacokinetics, Safety, Tolerability and Food Effects of Multiple Formulations of PRAX-114
A Phase 2 Clinical Trial of PRAX-114 to Assess the Safety, Tolerability, Pharmacokinetics, and Efficacy in Participants with Major Depressive Disorder
A Phase 1, Double-Blind, Placebo-Controlled, Randomized Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Multiple-Ascending Doses of PRAX-114 in Healthy Subjects
100 项与 Praxis Precision Medicines Australia Pty Ltd. 相关的临床结果
0 项与 Praxis Precision Medicines Australia Pty Ltd. 相关的专利（医药）
100 项与 Praxis Precision Medicines Australia Pty Ltd. 相关的药物交易
100 项与 Praxis Precision Medicines Australia Pty Ltd. 相关的转化医学
